All In Biotech

Drug Trial Radar · NCT07043946

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

A Phase 1b/2a, Open-Label, Sequential-Cohort, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Effectiveness of Budoprutug (TNT119) in Subjects With Immune Thrombocytopenia (ITP)

Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Jun 30, 2025

Primary completion

Aug 2027

Study completion Aug 2028

Sponsor

Lead sponsor
Climb Bio, Inc.Industry
Sponsor type
Industry
First posted
Jun 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective is to assess the safety and tolerability of budoprutug in adults with ITP. Pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy will also be assessed.

Conditions

  • Immune Thrombocytopenia (ITP)
  • ITP
  • Biologics
  • Monoclonal
  • Anti-CD19

Interventions

  • BudoprutugDrug

    Single IV dose of study product on Day 1 and Day 15

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to week 48

Locations

20 sites in 5 countries. Site status is shown where the registry gives one.

  • Climb Bio Investigative Site #359202

    Plovdiv, Bulgaria · Recruiting

  • Climb Bio Investigative Site #359203

    Plovdiv, Bulgaria · Recruiting

  • Climb Bio Investigative Site #359201

    Sofia, Bulgaria · Recruiting

  • Climb Bio Investigative Site #300202

    Ioannina, Greece · Recruiting

  • Climb Bio Investigative Site #300201

    Thessaloniki, Greece · Recruiting

  • Climb Bio Investigative Site #300204

    Athens, Attica, Greece · Recruiting

  • Climb Bio Investigative Site #300203

    Chaïdári, Attica, Greece · Recruiting

  • Climb Bio Investigative Site #381201

    Belgrade, Serbia · Recruiting

  • Climb Bio Investigative Site #381202

    Belgrade, Serbia · Recruiting

  • Climb Bio Investigative Site #381203

    Novi Sad, Serbia · Recruiting

  • Climb Bio Investigative Site #340206

    Burgos, Spain · Not yet recruiting

  • Climb Bio Investigative Site #340204

    Madrid, Spain · Recruiting

  • Climb Bio Investigative Site #340202

    San Pedro, Spain · Recruiting

  • Climb Bio Investigative Site #340203

    Valencia, Spain · Recruiting

  • Climb Bio Investigative Site #380208

    Cherkasy, Ukraine · Not yet recruiting

  • Climb Investigative Site #380204

    Ivano-Frankivsk, Ukraine · Recruiting

  • Climb Investigative Site #2380203

    Kyiv, Ukraine · Recruiting

  • Climb Investigative Site #380202

    Kyiv, Ukraine · Recruiting

  • Climb Investigative Site #380206

    Kyiv, Ukraine · Recruiting

  • Climb Investigative Site #380201

    Lviv, Ukraine · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.